
Of the 7 commonly prescribed healthy #dietary patterns, 6 offered protective associations against increased cardiovascular disease risk among individuals with a history of #cancer. bit.ly/48qqNyd

TheCardiologyAdvisor.com offers specialists in the field of cardiology a comprehensive knowledge base of practical information and resources.

Of the 7 commonly prescribed healthy #dietary patterns, 6 offered protective associations against increased cardiovascular disease risk among individuals with a history of #cancer. bit.ly/48qqNyd

High social vulnerability is associated with an increased incidence of #hypertensive disorders of #pregnancy and neonatal intensive care unit admissions. bit.ly/4kmkBOR

#ScientificSessions26 - Maintaining healthy sleep habits does not protect adults from the increased risk for major adverse cardiovascular events associated with #TransportationNoise exposure. bit.ly/4zknvr9 #MACE

#ScientificSessions26 - Following a nearly 20-year decline, mortality rates associated with #ValvularHeartDisease in older adults have increased significantly and are expected to remain high over the next 2 decades. bit.ly/4iQF8J2

#ScientificSessions26 - Treatment with GLP-1 RAs yielded superior glycemic control and a reduced risk for major adverse cardiovascular events when compared with #metformin therapy. bit.ly/3UQ2NRY

#ScientificSessions26 - Providing medically tailored #meals to patients with #T2D and hypertension yields clinically meaningful reductions in hemoglobin A1c and blood pressure. bit.ly/48d7pVk

Our interview series for #ScientificSessions26 continues! 🎙️ Kevin Kwaku, MD, PhD, and president of the Association of Black Cardiologists discusses the effect of #AI on cardiovascular healthcare #disparities. bit.ly/4iElrFA

Our interview series for #ScientificSessions26 continues! 🎙️ Philippe Généreux, MD, discusses the #PROGRESS trial and how it evaluated transcatheter aortic valve replacement vs surveillance in patients with moderate #AorticStenosis. bit.ly/4zcJbW9 #TAVR

Our interview series for #ScientificSessions26 continues! 🎙️ Dr Paul Ridker discusses the #ZEUS trial, which evaluated an interleukin-6 inhibitor in patients with chronic kidney disease and #atherosclerosis. bit.ly/3WsOkvM

Our interview series for #ScientificSessions26 continues! 🎙️ Gregg Sherman, MD, and Karol Watson, MD, PhD, discuss the results of the #HORIZON trial and lipoprotein(a). bit.ly/4fs0awu

UPDATE: The FDA approved Sunharbo (asundexian) for secondary #stroke prevention. Check out our recent #ScientificSessions26 interview with Dr Mukul Sharma, where he discusses #asundexian and the results of the OCEANIC-STROKE trial. bit.ly/4sZDERp

Check out our recent video interview series covering #ScientificSessions26! Dr David Bharucha discusses the use of #etripamil for recurrent paroxysmal supraventricular #tachycardia following ablation. bit.ly/4k5ayxy

Check out our recent video interview series covering #ScientificSessions26! Dr Wei Zhang discusses study results from a trial comparing sacubitril/valsartan with #valsartan alone. bit.ly/3Vo222F #tachyarrhythmia #ablation

Check out our recent video interview series covering #ScientificSessions26! Dr Karla Santo and Dr Otavio Berwanger compare results from OPTIMAL-#DIABETES and OPTIMAL-#STROKE. bit.ly/4zE4alI

Check out our recent video interview series covering #ScientificSessions26! Dr Gisele Sampaio Silva and Dr Otavio Berwanger discuss the results from the OPTIMAL-STROKE trial. bit.ly/3UKyUSP #Stroke

#ScientificSessions26 - Treatment with dapagliflozin improves estimated #glomerular filtration rate over a 12-month period in adult patients who have received #HeartTransplantation. bit.ly/4zAnQqD